Diabetes mellitus Posts - Page 4 of 108 on Medivizor
Navigation Menu

Diabetes mellitus Posts on Medivizor

Evaluating the effectiveness and safety of eplerenone treatment for patients with diabetic kidney disease.

Evaluating the effectiveness and safety of eplerenone treatment for patients with diabetic kidney disease.

Posted by on Sep 11, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study assessed the effectiveness and safety of eplerenone (Inspra) treatment for diabetic nephropathy (DN; diabetic kidney disease) in patients with type 2 diabetes (T2D). The data showed that eplerenone can be an effective supplement to existing clinical treatment in patients with DN. Some background DN is kidney damage...

Read More

Can teneligliptin be safely and effectively given to patients with inadequately controlled type 2 diabetes by triple oral antidiabetic drug treatment?

Can teneligliptin be safely and effectively given to patients with inadequately controlled type 2 diabetes by triple oral antidiabetic drug treatment?

Posted by on Sep 11, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study compared the effectiveness and safety of teneligliptin (Tenelia) to placebo in patients with type 2 diabetes (T2D) that was inadequately controlled with triple oral antidiabetic drugs (OADs). The study showed that teneligliptin may be considered as a fourth add-on OAD treatment in these patients. Some background T2D is...

Read More

Evaluating the effectiveness, durability, and safety of faricimab in patients with diabetic macular edema.

Evaluating the effectiveness, durability, and safety of faricimab in patients with diabetic macular edema.

Posted by on Jul 16, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the effectiveness, durability, and safety of faricimab (Vabysmo) for the treatment of patients with diabetic macular edema (DME). The data showed that faricimab with extended dosing up to every 16 weeks was safe and showed good vision gains and clinical improvements in these patients. Some background...

Read More

Comparing the effects of a ketogenic diet app versus a calorie restricted, low-fat diet on weight loss in patients with overweight or obesity.

Comparing the effects of a ketogenic diet app versus a calorie restricted, low-fat diet on weight loss in patients with overweight or obesity.

Posted by on Jun 26, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study compared the effects of a ketogenic diet mobile health application (Keyto app) with breath acetone biofeedback (device) versus a calorie-restricted, low-fat diet (WW; weight watchers) app on weight loss and metabolic risk in patients with overweight or obesity. The data showed that a ketogenic diet app with a breath acetone...

Read More

Can canagliflozin improve insulin resistance and internal fat tissue in patients with type 2 diabetes better than metformin?

Can canagliflozin improve insulin resistance and internal fat tissue in patients with type 2 diabetes better than metformin?

Posted by on May 31, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study assessed the effects of canagliflozin (Invokana) therapy on body composition, glucose control, insulin resistance, and systemic (whole body) inflammation in patients with newly-diagnosed type 2 diabetes (T2D) compared to metformin (Glucophage). The data showed that canagliflozin therapy reduced visceral fat tissue, and...

Read More

Does diabetes affect lower urinary tract symptoms in patients with benign prostatic hyperplasia?

Does diabetes affect lower urinary tract symptoms in patients with benign prostatic hyperplasia?

Posted by on May 31, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study reviewed the effect of diabetes on lower urinary tract symptoms (LUTS) in patients with benign prostatic hyperplasia (BPH). The data suggested that LUTS were increased in patients with BPH that had diabetes compared to patients without diabetes. Some background Men above 50 years of age frequently experience LUTS due to...

Read More

Can a low-carbohydrate diet affect insulin-resistant lipoprotein metabolism?

Can a low-carbohydrate diet affect insulin-resistant lipoprotein metabolism?

Posted by on May 31, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study determined the effect of varying carbohydrate and saturated fat dietary contents on cardiovascular disease (CVD) risk factors during weight-loss maintenance. The authors concluded that restriction of carbohydrates provided improved insulin resistance on lipoprotein metabolism, without unwanted side effects on low-density...

Read More

Can a ketogenic diet affect patients newly diagnosed with type 2 diabetes that are obese or overweight?

Can a ketogenic diet affect patients newly diagnosed with type 2 diabetes that are obese or overweight?

Posted by on May 31, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study observed the effectiveness of a ketogenic diet (KD) in patients newly diagnosed with type 2 diabetes (T2D) that were overweight or obese. The authors concluded that a DK can control body weight, blood glucose, and blood lipids (fats) in these patients but long-term adherence is a challenge. Some background...

Read More

How safe and well-tolerated is high-dose daily administration of vitamin D3 supplementation in persons with prediabetes?

How safe and well-tolerated is high-dose daily administration of vitamin D3 supplementation in persons with prediabetes?

Posted by on May 31, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study assessed the safety and effectiveness of oral, high-dose daily vitamin D3 for the prevention of diabetes in adults at high risk for type 2 diabetes (T2D). The authors concluded that oral, high-dose daily vitamin D3 at a dose of 4000 IU was safe and well-tolerated in patients with prediabetes that were overweight or...

Read More

Diabetes prevalence differs by race

Diabetes prevalence differs by race

Posted by on May 25, 2022 in Diabetes mellitus |

Diabetes is complex. Many factors influence your risk of developing diabetes, including race. The way race is associated with diabetes risk may change the way physicians screen patients for the disease. Size  Being overweight has been identified as a factor in diabetes, and may serve as a cue for screening. The United States Preventive Services...

Read More

Does metformin use decrease the risk of hospitalization and mortality from COVID-19?

Does metformin use decrease the risk of hospitalization and mortality from COVID-19?

Posted by on May 8, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study assessed the link between metformin (Glucophage) use in hospitalized and non-hospitalized patients with diabetes and different outcomes due to coronavirus disease 2019 (COVID-19). The study showed that metformin use was associated with a protective effect in COVID-19 outcomes in patients with type 2 diabetes (T2D). Some...

Read More

Is there a long-term effect of weight loss surgery on major adverse cardiovascular events in patients with diabetes and hypertension?

Is there a long-term effect of weight loss surgery on major adverse cardiovascular events in patients with diabetes and hypertension?

Posted by on May 8, 2022 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the long-term relationship between bariatric surgery (BS; weight loss surgery) and major adverse cardiovascular events (MACE) in patients with obesity, diabetes, and hypertension (high blood pressure; BP). The study showed that a sustained decrease in MACE occurrence was associated with BS in...

Read More